Status:
COMPLETED
Long-term Outcomes in Long Standing Persistent Atrial Fibrillation
Lead Sponsor:
Royal Brompton & Harefield NHS Foundation Trust
Collaborating Sponsors:
Liverpool Heart and Chest Hospital NHS Foundation Trust
Brighton and Sussex University Hospitals NHS Trust
Conditions:
Long Standing Persistent Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
Atrial fibrillation (AF) is a condition detected as an irregular heartbeat. It is the most common rhythm disturbance worldwide which can lead to significant symptoms and serious health problems (strok...
Detailed Description
This study involves participants from the randomised clinical trial which was just completed (CASA AF RCT: NCT02755688; ISRCTN18250790 ). They have undergone relevant ablation procedures in a randomis...
Eligibility Criteria
Inclusion
- CASA-AF RCT participants who have undergone ablative procedure to treat their LSPAF, completed 12 months follow up and consented to keep their implanted loop recorders in situ with weekly data downloads.
Exclusion
- There are no exclusion criteria for this study.
Key Trial Info
Start Date :
February 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2022
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT04280042
Start Date
February 1 2020
End Date
February 1 2022
Last Update
May 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Brompton and Harefield NHS Trust
London, United Kingdom